ebook Munafa Stock Market Course + Intraday & FNO calls  

MDGL announcements Madrigal Pharmaceuticals, Inc. announcements and dividends declared USA

Madrigal Pharmaceuticals, Inc. Complete list of announcements declared & dividend announcements by Madrigal Pharmaceuticals, Inc. MDGL

Madrigal Pharmaceuticals, Inc. MDGL listed on USA and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Madrigal Pharmaceuticals, Inc. MDGL

Madrigal Pharmaceuticals Posts Wider Loss In Q1
(RTTNews) - Wednesday, Madrigal Pharmaceuticals, Inc. (MDGL) announced its first-quarter financial results, reporting a net loss of .4 million, or .25 a share, compared to .2 million, or .61 a share, in the previous year.
Announcement as on 06 May 2026

Wall Street Thinks Madrigal Pharmaceuticals Could Climb 93%. Here's Why It Could Happen Soon.
Madrigal Pharmaceuticals (NASDAQ: MDGL) may not be a familiar name to many investors, but the consensus of Wall Street analysts expects its shares to rise by 93% within the next 12 months. That's assuming its lead candidate, resmetirom, is approved for sal
Announcement as on 27 September 2023

HC Wainwright & Co. Reiterates Madrigal Pharmaceuticals (MDGL) Buy Recommendation
Fintel reports that on September 14, 2023, HC Wainwright & Co. reiterated coverage of Madrigal Pharmaceuticals (NASDAQ:MDGL) with a Buy recommendation.
Announcement as on 14 September 2023

: Madrigal Pharmaceuticals shares fall after new CEO named
Shares of Madrigal Pharmaceuticals Inc. MDGL fell more than 7% premarket on Monday after the company appointed Bill Sibold, a former Sanofi SNY executive, as its new CEO. Sibold succeeds Dr. Paul Friedman, the company’s CEO since 2016, who will continue
Announcement as on 11 September 2023

: Madrigal Pharmaceuticals’ stock up 5% as company starts rolling submission for FDA approval of NASH treatment
Madrigal Pharmaceuticals Inc.’s stock MDGL rose 5% Friday after the company said it has started a rolling submission of a New Drug Application to the U.S. Food and Drug Administration seeking accelerated approval of its resmetirom as a treatment for, non
Announcement as on 30 June 2023

Announcements by Madrigal Pharmaceuticals, Inc. first page | Next page |

MDGL Madrigal Pharmaceuticals, Inc. current price & indicator signals

Moving Averages for Madrigal Pharmaceuticals, Inc.

  • 5Day Average: 430.2
  • 12Day Average: 420.06
  • 20Day Average: 430.5
  • 50Day Average: 475.72
  • 100Day Average: 502.69
  • 150Day Average: 504.9
  • 200Day Average: 496.93

MDGL Indicators & signals

Indicator MACD (12,26,9)

426.2, 440.53, -18.11
Indicator MACD is in negative zone

Indicator ADX (14)

1.93, 25.52, 24.55
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 48
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of MDGL Madrigal Pharmaceuticals, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
13 Fri Nov 2026 427.39 414.16 to 428.90 0.51% 0.51 times
12 Thu Nov 2026 425.21 423.19 to 434.48 -1.81% 0.45 times
11 Wed Nov 2026 433.03 431.55 to 440.21 0.1% 0.34 times
10 Tue Nov 2026 432.60 424.02 to 443.30 -0.04% 0.53 times
09 Mon Nov 2026 432.79 402.00 to 438.74 8.3% 0.66 times
06 Fri Nov 2026 399.63 378.28 to 401.61 -0.12% 1.25 times
05 Thu Nov 2026 400.10 389.32 to 411.95 -0.08% 0.99 times
04 Wed Nov 2026 400.43 353.54 to 402.48 1.04% 2.66 times
03 Tue Nov 2026 396.32 387.33 to 482.73 -8.08% 2.27 times
02 Mon Nov 2026 431.16 425.33 to 436.74 0.19% 0.57 times
30 Fri Oct 2026 430.36 424.99 to 437.80 -0.31% 0.29 times
29 Thu Oct 2026 431.70 427.45 to 445.66 0.16% 0.31 times

Videos related to: MDGL announcements Madrigal Pharmaceuticals, Inc. announcements and dividends declared USA

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

MDGL announcements Madrigal Pharmaceuticals, Inc. announcements and dividends declared USA

 

Back to top